Insider Transactions in Q4 2024 at Dyne Therapeutics, Inc. (DYN)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
1,455
-1.13%
|
$40,740
$28.12 P/Share
|
|
Dec 11
2024
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,334
-1.14%
|
$65,352
$28.12 P/Share
|
|
Dec 09
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
34,437
-0.63%
|
$998,673
$29.18 P/Share
|
|
Dec 06
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
101,675
-1.84%
|
$2,948,575
$29.34 P/Share
|
|
Dec 05
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
3,806
-0.07%
|
$110,374
$29.05 P/Share
|
|
Dec 04
2024
|
Oxana Beskrovnaya Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
66,500
+14.98%
|
-
|
|
Dec 04
2024
|
John Cox CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
145,300
+49.15%
|
-
|
|
Dec 04
2024
|
Douglas Kerr Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,000
+33.45%
|
-
|
|
Dec 04
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
BUY
Grant, award, or other acquisition
|
Direct |
32,700
+20.28%
|
-
|
|
Dec 04
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
135,039
-2.38%
|
$3,916,131
$29.39 P/Share
|
|
Dec 04
2024
|
Johanna Friedl Naderer Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,800
+28.21%
|
-
|
|
Dec 03
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
29,732
-0.52%
|
$862,228
$29.05 P/Share
|
|
Dec 02
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
81,201
-0.7%
|
$2,436,030
$30.02 P/Share
|
|
Nov 18
2024
|
Carlo Incerti |
SELL
Open market or private sale
|
Direct |
16,500
-100.0%
|
$462,000
$28.73 P/Share
|
|
Nov 18
2024
|
Carlo Incerti |
BUY
Exercise of conversion of derivative security
|
Direct |
16,500
+50.0%
|
$132,000
$8.69 P/Share
|
|
Nov 18
2024
|
Oxana Beskrovnaya Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
2,856
-2.03%
|
$79,968
$28.2 P/Share
|
|
Nov 18
2024
|
Richard William Scalzo SVP, Head of Finance & Admin. |
SELL
Open market or private sale
|
Direct |
2,735
-2.77%
|
$76,580
$28.2 P/Share
|
|
Nov 14
2024
|
Jason P Rhodes |
SELL
Open market or private sale
|
Indirect |
782
-0.01%
|
$25,806
$33.1 P/Share
|
|
Nov 14
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
8,929
-0.15%
|
$285,728
$32.82 P/Share
|
|
Nov 13
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
10,803
-14.78%
|
$378,105
$35.24 P/Share
|
|
Oct 21
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
121
-0.17%
|
$4,235
$35.06 P/Share
|
|
Oct 18
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
13,414
-15.48%
|
$469,490
$35.16 P/Share
|
|
Oct 17
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
13,013
-13.06%
|
$455,455
$35.17 P/Share
|
|
Oct 16
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
23,671
-19.19%
|
$828,485
$35.35 P/Share
|
|
Oct 03
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
5,441
-4.23%
|
$190,435
$35.13 P/Share
|
|
Oct 02
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
21,518
-14.32%
|
$753,130
$35.38 P/Share
|
|
Oct 01
2024
|
Dirk Kersten |
SELL
Open market or private sale
|
Indirect |
8,423
-5.31%
|
$294,805
$35.16 P/Share
|